Hangzhou Berry Genomics Genetic Diagnostic Technology Co., Ltd.

Hangzhou Berry Genomics Genetic Diagnostic Technology Co., Ltd. is a wholly-owned subsidiary of Beijing Berry Genomics Corporation, the first domestic genetic industry company listed on the main board. It undertakes the Group's R&D and production functions for in vitro diagnostic reagents and high-throughput sequencers. The company was recognized as a National High-tech Enterprise and a Hangzhou High-tech Enterprise in 2015. Taking congenital genetic disease screening and diagnosis as its breakthrough, the company applies high-throughput sequencing technology to prenatal screening and diagnosis, has developed the proprietary "non-invasive DNA prenatal testing" technology, and formed a complete patented technology system. In 2016, sales of products based on the "non-invasive DNA prenatal testing" technology reached RMB 280 million. The company will continue to carry out sustained research and development of genetic testing services around high-throughput gene sequencing technology, committed to creating more safe, accurate, economical and efficient genetic testing products, and making its modest contribution to human health.